BIOMAT Database Logo BIOMAT Database Logo

Intramuscular administration of phenytoin. 1966

M Dam, and V Olesen

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Dam, and V Olesen
Maintenance of therapeutic phenytoin plasma levels via intramuscular administration.
September 1976, Annals of internal medicine,
M Dam, and V Olesen
Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.
January 2002, European journal of drug metabolism and pharmacokinetics,
M Dam, and V Olesen
Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration.
November 1989, Journal of pharmaceutical sciences,
M Dam, and V Olesen
Oral and intramuscular phenytoin.
March 1976, Clinical pharmacology and therapeutics,
M Dam, and V Olesen
Letter: Intramuscular versus oral phenytoin.
March 1976, Archives of disease in childhood,
M Dam, and V Olesen
[Phenytoin and phenytoin derivatives for local administration].
June 1991, Die Pharmazie,
M Dam, and V Olesen
IV administration of phenytoin.
January 1990, Journal of general internal medicine,
M Dam, and V Olesen
Intravenous administration of phenytoin.
May 1979, Neurology,
M Dam, and V Olesen
Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
October 1975, Clinical pharmacology and therapeutics,
M Dam, and V Olesen
Controversy over administration of phenytoin.
August 2001, Critical care nurse,
Copied contents to your clipboard!